dimecres, 9 de gener del 2019

Zoll Medical acquires Payor Logic

Zoll, Payor Logic

Zoll Medical said today that it acquired healthcare software solution developer Payor Logic for an undisclosed amount.

Centerville, Ohio-based Payor Logic develops and supports accounts receivable software solutions specifically for the healthcare industry. The solutions are intended for use by emergency medical services, emergency physicians, DME providers, hospitals and labs, Zoll said.

“In today’s environment, healthcare organizations must consider the bottom line across their operations. We’ve always delivered better efficiencies to our customers, but with Payor Logic technology, our customers will see unprecedented improvement on their bottom line. Some customers have increased total payments by over 110 percent, and improved claim processing throughput by 88 percent. With this acquisition, Zoll can bring that level of A/R efficiency to hundreds of organizations across the healthcare spectrum, offering better financial performance, freeing up capital to reinvest in their operations and ultimately providing better patient care,” Zoll data systems prez Alex Moghadam said in prepared remarks.

Payor Logic has worked with Chelmsford, Mass.-based Zoll since 2015, the companies said, providing its services as part of Zoll’s Billing Pro solution.

“Payor Logic has always been recognized for our ability to increase reimbursements for healthcare providers, most of whom can’t afford to leave any revenue on the table. Our innovative solutions are truly unique, and we are pleased to join Zoll and leverage their reach and strategic vision to deliver these benefits to a wider segment of the market,” Payor Logic founding partner Ted Williams said in a press release.

Last summer, Zoll Medical said that it won more than $5 million with an arbitrator’s decision in its spat with former partner AutoMedx.

The post Zoll Medical acquires Payor Logic appeared first on MassDevice.



from MassDevice http://bit.ly/2SJLuwp

Cap comentari:

Publica un comentari a l'entrada